EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
BI Asset Management Fondsmaeglerselskab A S Makes New $58.82 Million Investment in AstraZeneca PLC (NASDAQ:AZN)
Insigneo Advisory Services LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)
Mariner LLC Buys 25,998 Shares of AstraZeneca PLC (NASDAQ:AZN)
Dodge & Cox Sells 5,325 Shares of AstraZeneca PLC (NASDAQ:AZN)
Guggenheim Capital LLC Sells 7,836 Shares of AstraZeneca PLC (NASDAQ:AZN)
Bank of Nova Scotia Buys Shares of 4,761 AstraZeneca PLC (NASDAQ:AZN)
Antibody-drug Conjugates Innovations Research Report 2025: $227 Billion in Deals Signal ADC Market Boom - Pfizer and Daiichi Sankyo Emerge as Leading Trial Sponsors | Valuespectrum.com
AstraZeneca Subsidiary Accused of Soliris Drug Market Monopoly
BNP Paribas Begins Coverage on AstraZeneca (NASDAQ:AZN)
Bruce Murray's Top Picks: Meta, Eli Lilly & Linamar - BNN Bloomberg
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Six FTSE 100 stock ideas for the second quarter, according to Barclays
This industrial giant is the UK's largest business, but it's not a FTSE 100 stock!
EU pharma sector explains duty fears - World - Chinadaily.com.cn
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Causeway Capital Management LLC
The top 3 mistakes to avoid if the stock market crashes
AstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
CUHK joins hands with AstraZeneca to boost research into clinical practice | The Standard
Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?
AstraZeneca (NASDAQ:AZN) Now Covered by Analysts at BNP Paribas
Sanders Capital LLC Has $995.03 Million Position in AstraZeneca PLC (NASDAQ:AZN)
Bridgewater Associates LP Has $44.13 Million Position in AstraZeneca PLC (NASDAQ:AZN)
Kennedy Capital Management LLC Buys 35,977 Shares of AstraZeneca PLC (NASDAQ:AZN)
Q4 EPS Estimates for AstraZeneca Lowered by Zacks Research
A market rally could be coming for UK stocks: here's what I'm buying
Asthma control and opportunities to optimize management and the healthcare provider experience using the AsthmaOptimiser online tool in Dutch general practice: the CAPTURE study
Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation
AstraZeneca PLC (LSE:AZN) in Artisan International Fund Q3 2024
F M Investments LLC Has $1.45 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Bessemer Group Inc. Sells 4,115 Shares of AstraZeneca PLC (NASDAQ:AZN)
Invesco Ltd. Lowers Stock Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Legal & General Group Plc
Norges Bank Acquires Shares of 16,378 AstraZeneca PLC (NASDAQ:AZN)
How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives
Bronchodilators Market Grows with Rising Prevalence of Asthma and COPD Cases - Express Press Release Distribution
Act Two Investors LLC Lowers Holdings in AstraZeneca PLC (NASDAQ:AZN)
Zacks Research Decreases Earnings Estimates for AstraZeneca
Scotia Capital Inc. Sells 181,745 Shares of AstraZeneca PLC (NASDAQ:AZN)
DRW Securities LLC Lowers Stake in AstraZeneca PLC (NASDAQ:AZN)
Advisory Services Network LLC Has $1.28 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
First Foundation Advisors Trims Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Phoenix Financial Ltd.
AstraZeneca (NASDAQ:AZN) Shares Gap Down - Here's Why
AstraZeneca Chairman Says Drug Tariffs Would Harm Patients
Dymon Asia Capital Singapore PTE. LTD. Invests $1.05 Million in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (LON:AZN) Reaches New 52-Week Low - What's Next?
Serum sphingomyelin levels define oxyhemoglobin desaturation-related metabolic threshold in symptomatic obstructive sleep apnea
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
AstraZeneca fends off diabetes generic, for now
Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)
Clive Palmer-supported vaccine injury case 'incoherent', 'unintelligible' and 'ambiguous'
AstraZeneca Settles Covid-Shot Suit With Christian Salesman
AstraZeneca PLC (AZN) Shares Gap Down to $62 on Apr 9
AstraZeneca (AZN) Faces Challenges Amid Potential Tariffs
RHHBY, LLY, AZN Face Market Pressure Due to New Tariff Concerns
AstraZeneca (AZN): A Long-Term Growth Opportunity Under $70
Fmr LLC Sells 805,930 Shares of AstraZeneca PLC (NASDAQ:AZN)
Peapack Gladstone Financial Corp Sells 47,590 Shares of AstraZeneca PLC (NASDAQ:AZN)
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca
AstraZeneca's Camizestrant Shows Promise in SERENA-6 Breast Cancer Trial
AstraZeneca (AZN) Gains EU Nod for Imfinzi Combo in NSCLC Treatment
AstraZeneca (AZN) Gains EU Approval for Expanded Enhertu Use in Breast Cancer
AstraZeneca (AZN) Gains Momentum with EU Drug Approvals
AstraZeneca (AZN) Prepares for Upcoming Earnings Amid Stock Decline
Solrikitug Emerges as a Promising Anti-TSLP Therapy for Severe Asthma, Poised to Address Critical Unmet Needs | DelveInsight | ABNewswire
Modified pegRNAs mitigate scaffold-derived prime editing by-products
Autologous T cell therapy for PRAME + advanced solid tumors in HLA-A*02 + patients: a phase 1 trial
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients
AstraZeneca PLC (AZN) Stock Price Down 5.81% on Apr 7
Arete Wealth Advisors LLC Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Buy" from Brokerages
China, America and pay inject drama into AstraZeneca's AGM
Pitcairn Co. Cuts Stake in AstraZeneca PLC (NASDAQ:AZN)
Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI
AstraZeneca (NASDAQ:AZN) Shares Gap Up - What's Next?
Cinctive Capital Management LP Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (LON:AZN) Stock Price Passes Above 200-Day Moving Average - Time to Sell?
AstraZeneca PLC (AZN) Shares Down 6.67% on Apr 4
Daiichi Sankyo (4568) and AstraZeneca Receive EU Approval for Enhertu in Breast Cancer Treatment
Case: Patents/Antitrust (D. Del.)
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Nomura Asset Management Co. Ltd.
AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment
Policy Fallout Continues; Rise in Lung Cancer Screening; Going Public With Denials
Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare
AstraZeneca PLC (LON:AZN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
AIM ImmunoTech Inc. (AMEX:AIM) Q4 2024 Earnings Call Transcript
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
AstraZeneca CEO: China already a global innovation hub | govt.chinadaily.com.cn
AstraZeneca and Scientific Societies Unite for Multidisciplinary Care in Cardio-Renal-Metabolic Diseases
O Shaughnessy Asset Management LLC Cuts Stake in AstraZeneca PLC (NASDAQ:AZN)
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
Systems epigenetic approach towards non-invasive breast cancer detection
AstraZeneca CEO: China already a global innovation hub - Chinadaily.com.cn
Earnouts in M&A Transactions: Recent Decisions From Delaware
OncoHelix and AstraZeneca Partner to Provide Access to Liquid Biopsy Testing for Men with Prostate Cancer
Latest news
Morning Note: Fed Cautious on Tariffs; US-Japan Currency Tensions; Oil Up
Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold
